Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.01700
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease

Digestive Diseases and Sciences
PhysiologyGastroenterology
2018English

Rapid Response to Vedolizumab Therapy in Biologic-Naïve Patients With Inflammatory Bowel Diseases

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Anti-Inflammatory Effects of Chicanine on Murine Macrophage by Down-Regulating LPS-induced Inflammatory Cytokines in IκBα/MAPK/ERK Signaling Pathways

European Journal of Pharmacology
Pharmacology
2014English

Early Vedolizumab Trough Levels at Induction in Inflammatory Bowel Disease Patients With Treatment Failure During Maintenance

European Journal of Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Proinflammatory Cytokines in Irritable Bowel Syndrome: A Comparison With Inflammatory Bowel Disease

Intestinal Research
Gastroenterology
2020English

Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment

Frontiers in Immunology
AllergyImmunology
2018English

The Role of Cytokines in Inflammatory Bowel Disease

Mediators of Inflammation
ImmunologyCell Biology
1994English

Probiotics and Inflammatory Bowel Diseases

Postgraduate Medical Journal
Medicine
2006English

Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy

Drug Development Research
Drug Discovery
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy